Consensus Jiangsu Kanion Pharmaceutical Co.,Ltd.

Equities

600557

CNE000001CL7

End-of-day quote Shanghai S.E. Other stock markets 06:00:00 2024-05-09 pm EDT			5-day change	1st Jan Change
20.05 ^CNY	-1.33%		+2.19%	-2.29%

Apr. 25	Jiangsu Kanion Pharmaceutical Co.,Ltd. Equity Buyback Plan Extended till February 5, 2025.	CI
Apr. 12	Jiangsu Kanion Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Evolution of the average Target Price on Jiangsu Kanion Pharmaceutical Co.,Ltd.

Price target over the last 5 years

History of analyst recommendation changes

1f90534589e5ed8fb94335c7.N8fz7YxN8VssUqcRs5j7sNuzZ_EBlyCxMWGJF5NGP4Y.Z46hm_YpvDVWFsJH3dOK55qELsZo4mjmAgbCL-YnbOFovcKm3wSiEG468g~e5acd2df3129359e47d65ea188da836c

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

20.05 CNY

Average target price

25.17 CNY

Spread / Average Target

+25.55%

High Price Target

28.09 CNY

Spread / Highest target

+40.10%

Low Price Target

23 CNY

Spread / Lowest Target

+14.71%

Consensus detail

Consensus revision (last 18 months)

Ratings for Jiangsu Kanion Pharmaceutical Co.,Ltd.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar